ABCC2 and ovarian cancer: The underlying mechanisms ranged from reduced efflux activity and downregulation of ABCB1, ABCC1, ABCC2 and ABCG2 expression depending on the compound, as seen in breast and ovarian cancer cells, whereas in cervical cancer cells, the effects were independent of ABC transporter-mediated efflux inhibition.